chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Redness, swelling, pain, itching at the site, approximately 4 inches. Developed some wheezing later on.
Fatigue; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, FATIGUE (Fatigue), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  No treatment medications were reported
Information has been received from a certified MA concerning an 8 week old female who was vaccinated IM in the right thigh with a first dose of Comvax on 09-NOV-2000. On 09-NOV-2000, soon after receiving the vaccination, the pt experienced a knot at the injection site. The pt developed no other symptoms. The knot was still present when 4 month exam was performed on 10-JAN-2001. Subsequently, the pt recovered. No further information is available.
Sore arm, muscle pain,  rash, 3 inch diameter hard lump under skin at injections site along with itchiness, lump is very hot and red.   I did nothing no pain meds or cold compress.  Today is day 3 since this started and the I still have all symptoms but at far less intensity, I no longer have a rash, it disappeared on day 2.
This 5-month-old female subject was enrolled in a study. On 30th June 2014, the subject received the 1st dose of HepB vaccine (intramuscular). On 3rd September 2014, the subject received the 2nd dose of Rotavirus vaccine (oral), the 2nd dose of PENTACEL (intramuscular) and the 2nd dose of PREVNAR 13 (intramuscular). On 3rd October 2014 14:55, 95 days after receiving HepB vaccine and 30 days after receiving Rotavirus vaccine, PENTACEL and PREVNAR 13 the subject developed moderate - grade 2 chronic diarrhea. Serious criteria included hospitalization. The outcome of chronic diarrhea was recovered/resolved on 10th October 2014. The investigator considred that there was a reasonable possibility that the chronic diarrhea may have been caused by HepB vaccine, Rotavirus vaccine, PENTACEL and PREVNAR 13. Diagnostic results (unless otherwise stated, normal values were not provided): On 3rd October 2014, Blood calcium result was 10.6 mg/dL and Blood urea result was 2 mg/dL.
Information has been received on 24-OCT-2016 from a lawyer regarding a case in litigation concerning a male patient of unknown age. The patient has a history of never having chicken pox or shingles prior to March 2014. In March 2014, the patient was vaccinated with ZOSTAVAX. On or about 23-JUL-2014, the patient began suffering fatigue and myalgia. The patient subsequently began to experience increasing pain in the right side of his body and dehydration. On 20-AUG-2014, the patient experienced a seizure and was hospitalized with the diagnosis of herpes encephalitis. A neurologist told the patient that he had suffered brain damage. Upon release from the hospital on 29-AUG-2014, the patient was experiencing loss of balance, difficulty speaking coherently, and loss of attention. The patient subsequently developed ear and head pain and is easily disturbed by loud noises. As a direct and proximate result of his vaccination with ZOSTAVAX, the patient continues to experience ongoing symptoms, including imbalance, incoherence, shortened attention span, ear and head pain, and noise disturbance, all of which are believed to be caused by encephalitis and/or damage to his central nervous system. The patient's symptoms had resulted in physical limitations not present prior to vaccination with ZOSTAVAX. The patient also experiences mental and emotional distress due to the resulting physical limitations and seriousness of his condition. The patient's fiancé has been the patient's primary caretaker since his illness began in 2014. As a result of his vaccination with ZOSTAVAX, the patient sustained severe and permanent personal injuries. The patient suffered serious, progressive, permanent, and incurable injuries as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. Upon internal review, herpes encephalitis, seizure, and brain damage were considered to be medically significant. Herpes encephalitis, seizure, brain damage, damage to his central nervous system, fatigue, increasing pain in the right side of his body, dehydration, loss of balance/imbalance, difficulty speaking coherently/incoherence, loss of attention, ear and head pain, easily disturbed by loud noises/noise disturbance, shortened attention span, and myalgia were considered to be disabling. Additional information has been requested.
Post vax the patient developed a red area at the injection site, blotches over her body, a headache, tight chest and shaking.
Systemic: Chest Tightness / Heaviness / Pain-Severe, Additional Details: patient complains of severe chest pain, lethargy, and suspects it could be myocarditis. patient was encouraged to seek medical attention to rule out severe side effects to the vaccine. patients husband was able to drive her to seek medical care immediately
Patient was given Covid-19 vaccine for 12 and older instead of the 5-11 year old version. There was no symptoms and patient did well. F/U call later - patient doing well.
Child was extremely perturbed and spent the night in shallow, restless sleep. At the time a mild fever of about 100 degrees was detected. In the morning the area around the injection became visibly inflamed, extending up and down the front of the thigh, with the area immediately adjacent to the injection point becoming painful to the touch. The affected area was also extremely hard. Motor skills were affected and the child fell an unusual number of times that morning, at one point injuring themselves. After about 3 PM of the next day the symptoms abated.
Chills, swelling, warm to touch , redness on the right arm inject site area  and very itching
Sore throat, feeling achy, 101 degree fever, chills Taking Tylenol Multisymptom caplets
Prior to the vaccine I had a Shingles outbreak on 12/3 in which a disgusting yellow glaze developed on my face around my chin/lip area with terrible fever blisters inside my mouth and little painful blisters on my lower lip appeared as well, something I have never experienced in my life. Pain down inside my ear drum, down the ear tube below my neck which hurt extremely bad. I had severe scabbing all down the front of my face which stopped at the bottom of my chin and all of my teeth hurt and turn black in the gums. I feel all my teeth will eventually have to be pulled sooner than later and my whole chin and right cheek area was numb as well. Around 12/24 I noticed most of the scabs on my face beginning to heal, but the chin and right cheek area was still numb. I had severe sensitivity to cold drinks resulting in me having to drink hot drinks. But on 12/31 a few days after the vaccine I begin getting new sores and blisters everywhere and little, tiny bumps appeared at the lower lash line of my right eye. And my chin and right cheek area is still numb resulting in me not even being able to feel drool sometimes. The skin on my jaw line now hangs from all the inflammation. I begin healing from those blisters after a few days but again on 1/6 again new blister begin developing all inside my mouth again and I feel the Shingles outbreak is returning. I developed severe diarrhea; my stomach begins bloating where I could literally see it swelling in my face, so I tried using a rubbing therapy to help. I developed terrible pain in my stomach which has since been controlled. I developed severe vertigo for about an hr. resulting in me throwing up for about 1hr. My digestive system is now seeming to be going back towards normal. I have seen an eye surgeon who is monitoring my eyes.  And I am slowly recovery, but new blisters have appeared today.
By next am after injection reddened and warm to touch with increased swelling and discomfort distal and inferior to injection site (inner aspect of upper arm) reddened. Public health nurse called Dr. office and was seen immediately (within 24 hr of immunization). Put on steroids and Zyrtec. To be seen again on 11/1/07-At that visit-area improving.
suspected vaccination failure; meningitis; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Men B NVS (Meningococcal B vaccine) for prophylaxis.   The patient's past medical history included meningitis (Family History) (patient's uncle died due to meningitis).   On an unknown date, the patient received Meningococcal B vaccine. On an unknown date, unknown after receiving Meningococcal B vaccine, the patient experienced vaccination failure (serious criteria hospitalization and GSK medically significant) and meningitis (serious criteria hospitalization and GSK medically significant). On an unknown date, the outcome of the vaccination failure and meningitis were unknown.   It was unknown if the reporter considered the vaccination failure and meningitis to be related to Meningococcal B vaccine.  Additional details were provided as follows: The case was reported by patient's parent. The age at vaccination was not reported. The reporter's brother died of this same meningitis when he was young and there was no vaccine. The patient received vaccine and had meningitis. The patient was in the ICU.
Post vax, pt complained of itchy, raised and reddened area coming up on opposite arm that evening (late) and then again the next day. The next day, got raised areas on left arm but was never any redness or raised area or increased pain at injection site. No problems with dyspnea or throat. Did take po Benadryl X 2 with relief. Client phoned physician. No fever, nausea or vomiting.
No adverse reaction was noted during either the 15 minute wait period. Pt came to  vaccine site and was given a Janssen vaccine on 5/19/21, Pt then came back to the vaccine site and was given Pfizer ( lot # EW0153) on 5/30/21.  On the date of 5/30 pt denied getting any previous vaccine at the time of the interview.
Pt vacc. w/ DTP/MMR/HIB/OPV. Same day had a few red spots on abd. W/in a few days rash increased & went from white to purple- like a bruise. Fever 12/10-12/11 w/ swollen ankles/wrists AM of 12/11.  PMD said rash looked like viral hives.
Patient was administered a flu vaccine in error due to misunderstanding of requested vaccines.  This was the patient's 2nd flu vaccine of the season.  Patient received Covid vaccine and RSV as desired.  No adverse outcomes are known at this time.
Localized itching, redness, with a 3-inch diameter at injection site.  No pain.
fussy, went to sleep, stopped breathing, blue & pale, vomited; mom gave mouth to mouth resuscitation, & was driven to hosp ER; pt started breathing on own once arrived @ ER; no other illness present; pt became limp
Pneumonia shot given @ 11:00 a.m. - arm started aching @ 5pm. C/O stomach ache @ this time.  Layed down and rested. Went to bed @ 900/ pm. Ached all over. Reports "high temp" but did not take it. Took ADVIL - no relief/ took PERCOCET and slept the rest of the night. Denied SOB or respiratory involvement.
Initial literature report received on 01 Nov 2010: This patient participated in a prospective cohort study to evaluate T cell responses as correlates of protection against influenza following vaccination in older adults. The patients were vaccinated with Influenza virus vaccine 2007/2008 (manufacturer unknown, batch number: unknown) during the fall of 2007. The influenza surveillance was initiated at two study sites at the start of the influenza season in Jan 2008. The mean age of the study subjects was 74 years (range 60-92). Patients started reporting influenza-like illness symptoms. When reported symptoms met the ILI criteria and were within 5 days of onset, a nasal swab for detection of influenza virus was obtained during a home visit or a clinic visit. A laboratory diagnosis of influenza illness was confirmed by the detection of influenza virus in a polymerase chain reaction assay of the nasal swabs or a 4-fold or greater rise in the antibody titer after the illness. Subjects that met both clinical and at least one of the laboratory criteria were identified as laboratory-confirmed influenza. This patient had an antibody titer value of 5, 5, 5, and 80 after 0 weeks, 4 weeks, 10 weeks and 20 weeks of vaccination respectively. The patient had more than 4 fold increase in titer value and also tested positive for seroconversion of A/H3N2 strain. This patient was considered as an case of Influenza A/H3N2. The outcome was not reported.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 20-AUG-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, 0.5 ml, (lot # K009105, expiration date 21-JAN-2016) (route and dose were not reported). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the lowest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the first excursion was 24, 34 and R. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree) and the type of excursion (R/F) for the second excursion was 176, 48 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
R/O Deltoid Bursitis. Felt like the vaccine was give too high and too far forward.  Lots of pain on movement or palpation, enough to wake me and keep me awake
Red swollen and bumpy area at injection site; Red swollen and bumpy area at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Red swollen and bumpy area at injection site) and INJECTION SITE SWELLING (Red swollen and bumpy area at injection site) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE ERYTHEMA (Red swollen and bumpy area at injection site) and INJECTION SITE SWELLING (Red swollen and bumpy area at injection site). At the time of the report, INJECTION SITE ERYTHEMA (Red swollen and bumpy area at injection site) and INJECTION SITE SWELLING (Red swollen and bumpy area at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication were not provided No treatment medication information were not provided
Fever blisters on bottom lip; Shortness of breath 5 minutes after injection.
Sore Arm; Nausea; headache; Booster dose; About 36 hours experienced pretty severe raised hives over front trunk of body up onto neck and small amount on face; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FE3590) via an unspecified route of administration in the right arm on 06Oct2021 at 10:15 (at the age of 68-year-old) as DOSE 3 (BOOSTER), SINGLE for COVID-19 immunisation. The medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9266) via an unspecified route of administration in the right arm on 27Feb2021 (at the age of 67-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6207) via an unspecified route of administration in the right arm on 20Mar2021 (at the age of 67-years-old) as a single dose for COVID-19 immunisation. The patient also took previously azithromycin(Z-PAK) and experienced allergy, also took Macrobid and experienced allergy and hives. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Oct2021, in first 24 hours, the patient experienced sore arm, nausea and headache. On an unknown date in Oct2021, about 36 hours the patient experienced pretty severe raised hives over front trunk of body up onto neck and small amount on face. She immediately started allegra twice daily which tamped down with 24 hrs. The patient had no problems with breathing. The patient reported that she had first time reaction to any immunization. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event pretty severe raised hives over front trunk of body up onto neck and small amount on face and included treatment with fexofenadine hydrochloride (ALLEGRA) twice daily. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, nausea and headache were resolved on 07Oct2021, while the clinical outcome of the event pretty severe raised hives over front trunk of body up onto neck and small amount on face was resolved on an unknown date in Oct2021.  No follow-up attempts are possible. No further information is expected.
One week from administration a small red spot formed where vaccine was given. Red spot became larger in diameter, about one and a half inches in diameter. Did not cause itching, and it was somewhat scaly. It diasppeared slightly, but it is back again as of reporting.
Sudden onset of nausea, vomiting, no appetite, and insomnia 5 days after vaccination (2/16/23).  Presented to Emergency Room 2/16/23.   Symptoms worsened over the next several days, including worsening insomnia and onset of anxiety. Was prescribed scopolamine patch 1 mg and Compazine 5 mg for nausea. Lost 12+ pounds within approximately one week.  Prescribed Zolpidem 5 mg on 2/23/23 for insomnia with no relief.  Prescribed Hydroxyzine 25 mg, Lorazepam 0.5 mg on 2/24/23 with no relief for insomnia.  Prescribed Citalopram 40 mg 2/22/23 for onset of anxiety.  Vomiting subsided around 2/20/23 however, no appetite remains, early satiety remains, feel full quickly after small amounts of food
got the first shot. Later I got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient for himself or herself. The age at vaccination was not reported. The patient stated that, got the shingles vaccine and later got shingles. The patient was told they would have been worse. The patient did not consented to follow up as no patient details provided. For second dose refer case US2021AMR183410,Same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR183410:Same reporter
Two weeks after my second GARDASIL shot, I began experiencing excruciating body aches. I also contracted a fever that spiked to 102 and lasted for 3 straight weeks. The body aches were later diagnosed as the condition, Fibromyalgia. This is a lifelong condition that I battle every day. The following are symptoms of Fibromyalgia that I experience: My muscle and joints ache, I can no longer participate in any athletic sports, I have insomnia at night, fatigue during the day, bouts of depression, frequent urination, anxiety, impaired memory and concentration, skin sensitivities, Raynaud's Syndrome, and impaired coordination.
Reports scattered papular rash lateral and posterior neck extending upward behind both ears approximately 1 1/2 weeks after receiving the flu vaccine.
shaking little bit; felt weak; Headache; heartbeat was faster than normal; felt unwell; little bit dizzy; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heartbeat was faster than normal), TREMOR (shaking little bit), MALAISE (felt unwell), DIZZINESS (little bit dizzy) and ASTHENIA (felt weak) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced MALAISE (felt unwell) and DIZZINESS (little bit dizzy). On 11-Apr-2021, the patient experienced HEART RATE INCREASED (heartbeat was faster than normal) and HEADACHE (Headache). On 12-Apr-2021, the patient experienced TREMOR (shaking little bit) and ASTHENIA (felt weak). At the time of the report, HEART RATE INCREASED (heartbeat was faster than normal), TREMOR (shaking little bit), MALAISE (felt unwell), DIZZINESS (little bit dizzy), ASTHENIA (felt weak) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details reported.  Use of unspecified concomitant medications was mentioned.   Reporter did not allow further contact
Pt recvd vax & w/in 30 mins devel rash, itching, nausea, vomiting & resp distress;
Developed hives approximately 10 minutes after vaccine administration; hives were all over body, administered 13 mg of Benadryl, patient did not have any difficulty breathing, no wheezing on auscultation, per MD, pt discharged home and advised to continue Benadryl.
A day after the vaccine on 9/8/12 - pain (L) shoulder down (L) arm in certain arm positions only. Saw orthopedic MD 10/5/12 - irritation to muscle below (L) elbow - unknown cause. 10/12/12 - physical therapist said he thought symptoms related to flu vaccine.
Erythema & pain at site of injection which developed in 6 hours, fever of 101.6, severe mylagia & arthralgia, headache.  Most severe symptoms lasted 24 hours. Myalgia & arthralgia still present after 36 hours. Treated with Aleve & ice to injection site.
Information has been received from a woman working in a physician's office concerning a 4 year old male with asthma who on January 25, 2002 was vaccinated with a fist subcutaneous dose in the left thigh of varicella virus vaccine live (Oka/Merck) ( Lot #641151/1181L). Concomitant vaccine administered on the same day included a third subcutaneous dose in the left arm of poliovirus vaccine inactivated (Vero) (IPOL) (lot #T1390). The patient had mild asthma and a yeast diaper rash at the time of vaccination. It was reported that on November 13, 2005, the patient developed what appeared to be chickenpox lesions. with not more than 10 lesions. Symptomatic treatment was given for mild itching. Subsequently, the patient recovered. Additional information is not expected.
Patient received second dose of pfizer covid vaccine 8 days ago, developed symptoms 5days ago, and presented to the ER today with increasing severity of symptoms. Initial symptoms included fever, night sweats, arthralgias, diarrhea, and intractable vomiting. Upon admission, patient was noted to have a diffuse, painful, non-blanching petechial rash.